Hospital Initiative Virtual Diversion Awareness Training

Wednesday, January 21, 2026 | 1:00 p.m. to 2:00 p.m. EST | ZOOM

The Diversion Control Division of the Drug Enforcement Administration is pleased to present a webinar covering hospital/clinic inspections, recordkeeping requirements, and diversion awareness. This training primarily affects those in a hospital or clinic setting. Please see Agenda.

There is no registration fee for this event. Capacity is limited to the first 3,000 attendees.

The speaker will provide information regarding the following:

• A review of the Diversion Control Division of DEA
• A review of DEA inspections, recordkeeping requirements, and diversion awareness for Hospital/Clinic settings
• A review of common inspection findings

Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.

Register Now for the Virtual Seminar

Confirmation of registration will be sent to each attendee's email address.

Any questions regarding this conference may be directed to: VDAT@dea.gov

Washington Division - Lunch & Learn Web-series: "Strengthening our Partnerships"

Join the DEA Washington Division for our ongoing Lunch and Learn Web-Series: "Strengthening Our Partnerships." Each month, we host 30-minute LIVE sessions featuring DEA speakers and special guests who present and discuss critical information, regulations, and procedures related to the handling, dispensing, manufacturing, distribution, and prescribing of Controlled Substances. These sessions aim to prevent diversion and reduce drug overdoses and poisonings in the District of Columbia, Maryland, and Virginia (DMV).

Audience: DEA Registrants, local/state government officials and healthcare professionals in general.

Registration is required. There is no registration fee. This are LIVE events and not recorded. The program is informational only and not for credit.

Any questions regarding this event may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to: WashingtonDiversionOutreach@dea.gov

Fentanyl Free America - Pill Press Threat

Thursday, January 22, 2026 | 1:30 – 2:00 PM EST | WebEx Webinar Platform

Drug traffickers use pill presses to press fentanyl into counterfeit pills along with punches and dies to imprint markings and logos onto those pills, which produces pills that look like legitimate prescription medication — like oxycodone, Xanax, and Adderall — when those pills contain fentanyl, methamphetamine, and other deadly drugs. Gain valuable insights into DEA strategic actions, regulations, and procedures concerning the appropriate manufacturing, distribution, handling, dispensing, and prescribing of Controlled Substances.

Speaker:
Justin G. Wood - Diversion Program Manager, DEA Washington Division

Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)

---

Controlled Substances Trends

Thursday, January 29, 2026 | 1:30 – 2:00 PM EST | WebEx Webinar Platform

Join us for this unique opportunity to engage with experts and deepen your understanding of the critical role each of us plays in safeguarding our communities. Whether you're a law enforcement officer, healthcare provider, or community leader, your participation is vital in the fight against drug misuse and its devastating impacts. Get insights on national and local trends in controlled substances with a focus on Fentanyl, emerging drugs, and the DEA's Fentanyl Free America Initiative.

Moderator:
Justin G. Wood - Diversion Program Manager, DEA Washington Division

Speaker:
Christopher C. Goumenis - Special Agent in Charge - Washington Division

Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)

---

Preventing Diversion - Responsibilities of Handlers of Chemical Products

Thursday, February 05, 2026 | 1:30 – 2:00 PM EST | WebEx Webinar Platform

Attendees will gain understanding of the critical measures required to prevent the illegal distribution and misuse of controlled substances and precursor chemicals. The session will cover best practices for compliance, the importance of thorough documentation, and the proactive steps that can be taken to identify and mitigate potential risks. By fostering collaboration and sharing insights, participants will be better equipped to uphold the integrity of their operations and protect public health within the community.

Moderator:
Justin G. Wood - Diversion Program Manager, DEA Washington Division

Speaker:
Carlos Nazario - Staff Coordinator - DEA HQS Diversion Control Division

Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)